Business Description
Evoq Remedies Ltd
ISIN : INE0JVD01011
Total Employee Number:
8Compare
Compare
Traded in other countries / regions
543500.India IPO Date
2022-03-30Description
Evoq Remedies Ltd is engaged in the pharmaceutical business involving marketing, trading, and distribution of wide range of pharmaceutical formulation products such as anti-biotic drugs, calcium, multivitamins, injections, and others. It operates in a single segment that is Pharmaceutical Trading.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.07 | |||||
Equity-to-Asset | 0.85 | |||||
Debt-to-EBITDA | -0.37 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 1.86 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -10.8 | |||||
3-Year EBITDA Growth Rate | 68.8 | |||||
3-Year FCF Growth Rate | 66.7 | |||||
3-Year Book Growth Rate | -0.8 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 34.19 | |||||
9-Day RSI | 29.16 | |||||
14-Day RSI | 29.29 | |||||
3-1 Month Momentum % | -30.79 | |||||
6-1 Month Momentum % | -22.62 | |||||
12-1 Month Momentum % | -37.57 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 6.77 | |||||
Quick Ratio | 6.55 | |||||
Days Inventory | 28.07 | |||||
Days Sales Outstanding | 80.43 | |||||
Days Payable | 23.98 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -22.3 | |||||
Shareholder Yield % | 57.88 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 0.13 | |||||
Operating Margin % | -5.89 | |||||
Net Margin % | -0.94 | |||||
EBITDA Margin % | -0.78 | |||||
FCF Margin % | -1.11 | |||||
OCF Margin % | -1.11 | |||||
ROE % | -0.54 | |||||
ROA % | -0.47 | |||||
ROIC % | -2.91 | |||||
3-Year ROIIC % | 7.54 | |||||
ROC (Joel Greenblatt) % | -1.94 | |||||
ROCE % | -0.56 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 0.18 | |||||
PB Ratio | 0.1 | |||||
Price-to-Tangible-Book | 0.1 | |||||
EV-to-EBIT | -17.63 | |||||
EV-to-EBITDA | -22.14 | |||||
EV-to-Revenue | 0.18 | |||||
EV-to-FCF | -16.93 | |||||
Price-to-GF-Value | 0.14 | |||||
| Price-to-Net-Current-Asset-Value | 0.1 | |||||
Earnings Yield (Greenblatt) % | -5.66 | |||||
FCF Yield % | -6.47 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Evoq Remedies Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 255.068 | ||
| EPS (TTM) (₹) | -0.1 | ||
| Beta | 2.6618 | ||
| 3-Year Sharpe Ratio | -0.47 | ||
| 3-Year Sortino Ratio | -0.64 | ||
| Volatility % | 92.59 | ||
| 14-Day RSI | 29.29 | ||
| 14-Day ATR (₹) | 0.113819 | ||
| 20-Day SMA (₹) | 1.9805 | ||
| 12-1 Month Momentum % | -37.57 | ||
| 52-Week Range (₹) | 1.63 - 6.11 | ||
| Shares Outstanding (Mil) | 24.9 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Evoq Remedies Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Evoq Remedies Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Evoq Remedies Ltd Frequently Asked Questions
What is Evoq Remedies Ltd(BOM:543500)'s stock price today?
The current price of BOM:543500 is ₹1.75. The 52 week high of BOM:543500 is ₹6.11 and 52 week low is ₹1.63.
When is next earnings date of Evoq Remedies Ltd(BOM:543500)?
The next earnings date of Evoq Remedies Ltd(BOM:543500) is .
Does Evoq Remedies Ltd(BOM:543500) pay dividends? If so, how much?
Evoq Remedies Ltd(BOM:543500) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Evoq Remedies Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers